Free Trial
NASDAQ:LGVN

Longeveron (LGVN) Stock Price, News & Analysis

Longeveron logo
$1.42 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$1.42 0.00 (0.00%)
As of 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Longeveron Stock (NASDAQ:LGVN)

Key Stats

Today's Range
$1.38
$1.44
50-Day Range
$1.15
$1.66
52-Week Range
$1.14
$4.88
Volume
244,553 shs
Average Volume
757,970 shs
Market Capitalization
$21.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.67
Consensus Rating
Buy

Company Overview

Longeveron Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
70th Percentile Overall Score

LGVN MarketRank™: 

Longeveron scored higher than 70% of companies evaluated by MarketBeat, and ranked 318th out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Longeveron has received a consensus rating of Buy. The company's average rating score is 3.25, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Longeveron has received no research coverage in the past 90 days.

  • Read more about Longeveron's stock forecast and price target.
  • Earnings Growth

    Earnings for Longeveron are expected to grow in the coming year, from ($3.69) to ($1.42) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Longeveron is -0.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Longeveron is -0.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Longeveron has a P/B Ratio of 0.97. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Longeveron's valuation and earnings.
  • Percentage of Shares Shorted

    3.10% of the float of Longeveron has been sold short.
  • Short Interest Ratio / Days to Cover

    Longeveron has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Longeveron has recently decreased by 1.05%, indicating that investor sentiment is improving.
  • Dividend Yield

    Longeveron does not currently pay a dividend.

  • Dividend Growth

    Longeveron does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.10% of the float of Longeveron has been sold short.
  • Short Interest Ratio / Days to Cover

    Longeveron has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Longeveron has recently decreased by 1.05%, indicating that investor sentiment is improving.
  • News Sentiment

    Longeveron has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.01 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 9 news articles for Longeveron this week, compared to 1 article on an average week.
  • Search Interest

    5 people have searched for LGVN on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Longeveron insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $36,740.00 in company stock.

  • Percentage Held by Insiders

    11.20% of the stock of Longeveron is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 10.01% of the stock of Longeveron is held by institutions.

  • Read more about Longeveron's insider trading history.
Receive LGVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Longeveron and its competitors with MarketBeat's FREE daily newsletter.

LGVN Stock News Headlines

3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.
See More Headlines

LGVN Stock Analysis - Frequently Asked Questions

Longeveron's stock was trading at $1.73 on January 1st, 2025. Since then, LGVN shares have decreased by 17.9% and is now trading at $1.42.

Longeveron Inc. (NASDAQ:LGVN) announced its earnings results on Tuesday, November, 12th. The company reported ($0.34) earnings per share for the quarter, beating the consensus estimate of ($0.53) by $0.19. The business earned $0.77 million during the quarter, compared to analyst estimates of $0.34 million. Longeveron had a negative trailing twelve-month return on equity of 85.07% and a negative net margin of 760.72%.
Read the conference call transcript
.

Shares of Longeveron reverse split on Wednesday, March 27th 2024.The 1-10 reverse split was announced on Wednesday, March 27th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, March 27th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Longeveron (LGVN) raised $30 million in an initial public offering on Friday, February 12th 2021. The company issued 2,700,000 shares at a price of $10.00-$12.00 per share. Kingswood Capital Markets and Alexander Capital L.P. acted as the underwriters for the IPO.

Shares of LGVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Longeveron investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), NIO (NIO), AST SpaceMobile (ASTS), Virgin Galactic (SPCE) and Phunware (PHUN).

Company Calendar

Last Earnings
11/12/2024
Today
7/14/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:LGVN
CIK
1721484
Fax
N/A
Employees
20
Year Founded
N/A

Price Target and Rating

High Price Target
$10.00
Low Price Target
$6.00
Potential Upside/Downside
+510.3%
Consensus Rating
Buy
Rating Score (0-4)
3.25
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($6.28)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$15.97 million
Net Margins
-760.72%
Pretax Margin
-760.72%
Return on Equity
-85.07%
Return on Assets
-70.74%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.61
Quick Ratio
5.61

Sales & Book Value

Annual Sales
$2.23 million
Price / Sales
9.53
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.47 per share
Price / Book
0.97

Miscellaneous

Outstanding Shares
14,928,000
Free Float
13,256,000
Market Cap
$21.20 million
Optionable
Not Optionable
Beta
0.21
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:LGVN) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners